Advances in Acute Myeloid Leukemia: Recently Approved Therapies and Drugs in Development

SIMPLE SUMMARY: Acute myeloid leukemia (AML) is one of the most common types of leukemia in adults, with an average first diagnosis at age 68, and has historically carried poor prognosis due to various genetic alterations and abnormalities that complicate approaches to treatment. Recently, numerous...

Descripción completa

Detalles Bibliográficos
Autores principales: Stanchina, Michele, Soong, Deborah, Zheng-Lin, Binbin, Watts, Justin M., Taylor, Justin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692236/
https://www.ncbi.nlm.nih.gov/pubmed/33139625
http://dx.doi.org/10.3390/cancers12113225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692236/
https://www.ncbi.nlm.nih.gov/pubmed/33139625
http://dx.doi.org/10.3390/cancers12113225

Ejemplares similares